By Abhirup RoyMUMBAI (Reuters) - India's Bajaj Allianz Life Insurance is looking to raise its exposure to local IT services companies and drugmakers in 2019, drawn by attractive valuations and easing regulatory issues, even as a strengthening rupee threatens to hurt earnings.Strong free cash flows and growth in the main export market in the U.S. bode well for IT firms, while select pharmaceutical companies will benefit from the resolution of regulatory clampdowns and steady drug approvals, Sampath Reddy, chief investment officer at Bajaj Allianz Life told Reuters.The Indian rupee has weakened ...
MORE ON MARKETS:
Copyrights © 2020 Business Standard Private Ltd. All rights reserved.
Upgrade To Premium Services
Business Standard is happy to inform you of the launch of "Business Standard Premium Services"
As a premium subscriber you get an across device unfettered access to a range of services which include:
- Access Exclusive content - articles, features & opinion pieces
- Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
- Access to 17 plus years of content archives
- Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
- End of day news alerts on 5 companies (via email)
- NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
In Partnership with
Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.
Team Business Standard